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Abstract
This review article is aimed at comparing the results of histopathological and clinical imaging studies
to assess coronary atherosclerotic plaques in humans. In particular, the gap between the two
techniques and its effect on the understanding of the pathophysiological basis of coronary artery
disease is critically discussed.
Introduction
Amongst the clinical approaches ultrasound imaging is
one of the more promising technique to understand dys-
function. The need is to compare morphopathological
counterpart to have a correct pathophysiological
interpretation.
In four reviews, morphopathology of the main cardiovas-
cular disorders, in relation to the status of art of clinical
imaging will be presented. The aim is to recall the patho-
logical anatomy to stimulate ultrasound experts to further
sharpen their technology till "histological" perfection.
The present first review concerns the coronary atheroscle-
rosis since the current dogma of "unifying theory"
assumes that the acute coronary syndromes, namely
unstable angina, myocardial infarct and sudden death, are
caused by atherosclerotic plaque rupture or "explosion"
with occlusive thrombus formation preceded by intramy-
ocardial emboli. An assumption which implies to dis-
cover a clinical imaging able to show when a coronary
atherosclerotic plaque becomes vulnerable i.e. prone to
rupture.
The risk of the latter has been correlated with large lipid
core (atheroma in our definition), thin fibrous cap (< 65
µm) covering atheroma. Therefore any imaging should
have a 50 µm resolution to identify a fibrous cap prone to
rupture, 100 µm or 150 µm thickness being respectively at
low or minimal risk. Matrix-digesting enzymes released
from inflammatory cells (monocytes, macrophages, T-
cells, B-cells, neutrophils, mastcells) may contribute to
plaque rupture. An attractive approach since, despite
many years of preventive and therapeutical attempts, cor-
onary heart disease (CHD) remains the main cause of
death and morbidity in advanced societies and selects
people at the top of their work skillness and productivity.
The first question is whether ultrasound imaging may or
may not discriminate extent and morphology of plaque
variables seen within the intima.
Coronary atherosclerotic plaque
Physiological intimal thickening
Morphology of the atherosclerotic plaque has been
described in textbook and articles [1-4]. In comparing
many contributions, the major difficulty is to discriminate
among different morphologic patterns selected in
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Coronary physiologic intimal thickening Figure 1
Coronary physiologic intimal thickening. This changes starts as nodular (already visible at birth at the site of vessel bifurcation) 
smooth muscle cells (A) and elastic fibrils (B) hyperplasia which in the second decade is diffuse to the whole intimal surface of 
all extramural arterial vessels. With aging there is a progressive increase of fibrous tissue which substitutes myo-elastic tissue 
(C, D) with final total, anelastic, fibrosis (E, F). Arteriosclerosis distinct from atherosclerosisCardiovascular Ultrasound 2004, 2:29 http://www.cardiovascularultrasound.com/content/2/1/29
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Comparison between the intimal thickening of the LAD (A) and the middle cerebral artery (B) of the same 18-year old subject Figure 2
Comparison between the intimal thickening of the LAD (A) and the middle cerebral artery (B) of the same 18-year old subject. 
In the latter artery the intimal thickening is minimal in contrast to that of LAD which is circumferential with a thickness greater 
than tunica media. C), difference in maximal thickness in microns found in main coronary arteries and branches in respect of 
the middle cerebral artery. D), absence of intimal thickening in the LAD of dogs, despite and identical morpho-function. This 
suggests a possible role of the neurogenic control of coronary arteries in humans. On the other hand the absence of intimal 
thickening in the "mural tract" of coronary arterial vessels (E) emphasizes the role of systolic dynamic stresses on arterial wall 
free to expande versus those protected by encircling contracted myocardium.Cardiovascular Ultrasound 2004, 2:29 http://www.cardiovascularultrasound.com/content/2/1/29
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different groups of patients according to unclear defini-
tions and without distinction between the plaque
obtained by hypercholesterol diet and that found in the
general population. The other need is to consider the evo-
lution of a plaque in each single arterial system since any-
one has its own peculiarity with different response to
blood flow dynamics. In this sense, only the coronary
arteries have a diphasic blood flow in relation to the cycle
of myocardial contraction, i.e. filling of extramural vessels
without intramural flow in systole because contracted
myocardium compresses intramyocardial vessels. The
result is an excess of systolic radial, circumferential, longi-
tudinal and drag pressures on the wall of arteries and
branches free to expand on the cardiac surface. In turn,
this diphasic hemodynamic induces a structural response
of the coronary intima which starts as smooth muscle cell
proliferation from the tunica media, followed by elastic
fiber hyperplasia ending in fibrosis of the whole intima
without lumen reduction (Fig 1). First described by
Wolkoff in 1929, such thickening becomes greater in the
second decade in contrast to its absence in other human
muscular arteries (e.g. brain arteries) or in animal with a
similar coronary artery anatomy and diphasic flow (Fig.
2). The latter finding suggests that hemodynamic pres-
sures may have the intimal hyperplastic effect in associa-
tion with the neurovegetative regulation of arterial wall
tone particularly active in humans in relation to heart
function. Any clinical imaging of the coronary wall should
consider this physiological intimal thickening [3-5] which in
normal adult hearts measures about 200 µm, does not
show any atherosclerotic variable, may become thicker in
hypertrophic hearts with normal coronary artery and is
greatly reduced or absent in segments of extramural coro-
nary artery embedded ("mural artery") within the myocar-
dium. The latter abolishes the systolic arterial wall
expansion (Fig. 2).
The first conclusion is that such intimal thickening is a
physiologic structural respons to hemodynamics and not
the initial phase of atherosclerosis as claimed by some
authors.
Coronary atherosclerotic intimal thickening
In contrast to the uniformely diffuse physiological intimal
thickening, the atherosclerotic one is focal and protrudes
within the lumen which is progressively reduced. In order
to quantitatively study this progression, we sampled sys-
tematically in each heart the first tract of the main left
trunk (LCA), left descending (LAD) and circumflex (LCX)
branches, right coronary artery (RCA), posterior descend-
ing branch (PD) and the middle tract of LAD and mar-
ginal and posterior tracts of RCA. These selected tracts
correspond to the sites where atherosclerotic changes gen-
erally occur. The coronary arterial sampling was per-
formed in 100 fatal cases of acute myocardial infarct
without other diseases and not undergone invasive tech-
niques; 208 cases of sudden and unexpected coronary
death (SUD) which occurred in apparently normal peo-
ple, acting their usual life, without resuscitation attempts
and autopsy findings limited to coronary atherosclerosis
of any degree, myocardial necrosis or scar, with or without
cardiac hypertrophy: 50 cases with chronic angina pec-
toris who died within 25 day after coronary by-pass sur-
gery; and 97 normal subjects who died by accident
without pathological findings at autopsy but coronary
atherosclerosis. In a total of 3,640 coronary sections the
following variables were quantified:
1. Lumen reduction calculated in percent of the normal
diameter measured in normal coronary arteries and
branches injected by plastic substance under pressure.
Measurement often referred to the cross-sectional area
within the internal elastic membrane may result in severe
stenosis despite a normal lumen since the atherosclerotic
plaque may enlarge the cross-section.
2. Shape of residual lumen: concentric if encircled by path-
ological intima or semilunar when an arch of the wall was
normal.
3. Length calculated in number of segments involved by
the plaque, all extramural coronary arteries being sistem-
atically cross-sectioned at 3 mm interval.
4. Intimal and tunica media thickness measured in
microns.
5. Atherosclerotic changes within the intima: fibrosis alone,
basophilia  i.e. proteoglycan accumulation, atheroma  or
lipoprotein/cholesterol material, calcification, vasculariza-
tion, hemorrhage, adventitial and intimal lymphocytic infiltra-
tion. All these variables were expressed in percent of the
total intima but vascularization calculated in number of
vessels found.
Amongst 1,519 sections without lumen reduction with an
intimal physiological thickness less of 300 µm we never
found subendothelial or internal lipoprotein/cholesterol
infiltration or deposit (fatty streaks), monocytes or macro-
phages or foam cells, platelet aggregates, fibrin-platelet
thrombi or inflammatory elements. A similar negative
finding was observed in 1,315 coronary sections with a
lumen reduction less than 69% and pathological intimal
thickness less than 600 µm. In all these sections we were
unable to demonstrate an intimal fissuration. We must
emphasize that in selecting our material cases of familial
hypercholesterolemia were excluded.
In general the atherosclerotic intimal variables increased
in frequency and extent in parallel with the lumenCardiovascular Ultrasound 2004, 2:29 http://www.cardiovascularultrasound.com/content/2/1/29
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reduction and pathological intimal thickeness with the
exception of proteoglycan accumulation less found in
stenoses >90% and intimal thickness >2000 µm. Of 990
sections with calcification, 488 (49%) had mild stenosis,
calcification being severe in 162 (33%). This finding indi-
cates that calcification per se does not necessarily means a
severe lumen reduction. The less frequent variable was
intimal hemorrhage mainly seen in plaques located in a
vessel tributary to an acute infarct.
When different groups of CHD and normal people were
matched, an excess of atheroma, hemorrhage, calcifica-
tion and adventitial/intimal lymphocytic inflammation
was observed in AMI group while a significant defect was
present in normal subjects with the same degree of steno-
sis. In synthesis, two other main findings are worth of
mention: 1) proteoglycan accumulation is a relatively late
event which occurred in the deep layer of the intima near
to the tunica media and below the fibrous cap of a plaque.
Lipoprotein/cholesterol plus macrophages (foam cell)
and/or calcium salts appeared only in this proteoglycan
pool in agreement with their interaction with gly-
cosaminoglycans (Fig. 3); 2) adventitial inflammation
showed a peculiar tropism for the nervous structures
related to the media at plaque level only (medial neuritis).
An inflammatory process which involved all plaques
present in each CHD patient while absent or limited to
one plaque in normal controls.
This study induced the recognition of two types of coro-
nary atherosclerotic plaque: one, which belongs to the
general population, (including CHD patients) and starts
as nodular intraluminal proliferation of smooth muscle
cells followed by elastic tissue hyperplasia and final sub-
stitution by fibrous tissue. Subsequently, a deep prote-
oglycan pool forms and becomes a deposit of lipoprotein/
cholesterol and/or calcium salts. The recurrence of these
phenomena explains the radial, circumferential, longitu-
dinal progression of the coronary plaque resulting in
increasing lumen reduction. This type of myohyperplastic
plaque is totally different from the hypercholesterol plaque
obtained experimentally by hypercholesterol diet in ani-
mals free of atherosclerosis or observed in a small group
of patients with familial hypercholesterolemia. In litera-
ture too often the hypercholesterol plaque is taken as a
model of an atherosclerotic plaque in man [1]. In timing
the sequence of the events is important to stress that the
inflammatory lymphocytic-plasmacellular process
(autoimmune phenomenon?) starts after the proteogly-
can insudation, being a relatively late complication.
The recurrent basic changes in myohyperplastic plaque
(smooth muscle cell hyperplasia, fibrosis, proteoglycan
accumulation with atheroma and/or calcification) explain
the various intimal aspects amongst different plaques and
different tracts of the same plaque (Fig. 4). A synopsis
comparing dogma versus our findings is given in Table 1:
Targets of ultrasound diagnosis: the present and 
the future
Different echocardiographic techniques have been
employed in the attempt to provide adequate visualiza-
tion of coronary arteries (Table 2). However, intracoro-
nary ultrasound (ICUS) represents the most valuable
method to assess plaque morphology. Given to its limited
resolution (approximately 0.3 mm), angiography is a
fairly imprecise measure of luminal morphology and size.
In particular, it is deficient in providing adequate distinc-
tion between plaque and lumen irregularities and assess-
ing the extent of atherosclerotic disease [6]. Both these
issues appear to be much well defined by ICUS. Firstly, the
tomographic orientation of ultrasound enables a visuali-
zation of the full circumference of the vessel wall and,
therefore, a more accurate assessment of size [7-9]. In
addition, it allow us to overcome the false assumption
that the nonstenotic region surrounding a discrete steno-
sis is normal and, therefore, to obtain an unbiased assess-
ment of the plaque burden at the site of the stenosis.
Finally, the penetrating nature of ultrasound provides
unique images of the atherosclerotic plaque.
ICUS image analysis has been extensively used for deter-
mining plaque composition [10-13]. However, there are
some limitations to this approach: 1) digitizing
videotapes is time-consuming and therefore not suitable
for real-time analysis; (2) image resolution is reduced to
that of videotape, approximately 330 µm; (3) parameters
such as gain, including time gain compensation and
intensity, can be adjusted by the operator, thereby adding
variability to the data set; (4) the dynamic range, pre- and
postprocessing of the images depend on the analog-to-
digital converters used in the ICUS consoles; (5) finally,
due to the small dimension of the transducer, the trans-
mitted acustic energy is low. Thus, some concerns still
exist on whether this technique is ready to go for clinical
use. In particular, definition of plaque composition seems
not enough reproducible to provide an alternative inde-
pendent standard to quantitative histology [14].
New technical development based on noninvasive molec-
ular imaging [15,16], such as the use of novel targeted
contrast agents able to identify fibrin deposited within
plaque microfissures [17], adhesion or thrombogenic
molecules expressed on endothelium of vulnerable
plaques [18-22], matrix metalloproteinases in the cores of
progressing lesions [23], or even early angiogenic expan-
sion of the vasa vasorum that supports plaque develop-
ment [24], will contribute to fill the gap between
information derived from direct, quantitative histology
and ultrasound imaging. Moreover, spectral analysis ofCardiovascular Ultrasound 2004, 2:29 http://www.cardiovascularultrasound.com/content/2/1/29
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Natural history of the coronary atherosclerotic plaque in general population, including most of CHD patients Figure 3
Natural history of the coronary atherosclerotic plaque in general population, including most of CHD patients. The starting 
point is a nodular hyperplasia of smooth muscle cells and elastic tissue with progressive fibrous replacement. No other changes 
as subendothelial lipo-protein-cholesterol storage, inflammatory process of any type, platelet aggregation and/or fibrin-platelet 
thrombi are found (A). Proteoglycan accumulation in the deep intima between tunica media and the fibrous cap is the second 
step (B). In this proteoglycan pool, lipo-protein/cholesterol cleft, in macrophages ("foam cells") and/or Ca++ salts appear. Vascu-
larization of the plaque and hemorrhage (C) follow. In the stage of proteoglycan accumulation, lympho-plasmacellular infiltrates 
occur in the adventitia and intima (C) with specific localization, around adventitial nerves closed to the tunica media (medial 
neuritis) (D, E). This natural history is totally different from that obtained experimentally by hypercholesterol diet in animals 
free of spontaneous atherosclerosis or in the small group of patients with familial hypercholesterolemia (F), in which transend-
othelial lipo-protein insudation is the starting point.Cardiovascular Ultrasound 2004, 2:29 http://www.cardiovascularultrasound.com/content/2/1/29
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Coronary atherosclerosis Figure 4
Coronary atherosclerosis. Different aspect of a severe, pin-point lesion (arrow). Plaque with prevailing atheroma (A) or fibro-
sis (B). Plaque with pale, large zone of proteoglycan accumulation (C) or with small atheroma plus hemorrhage and proteogly-
cans associated with critical stenosis occluded by an acute thrombus (D). Sequence in the same plaque of "rupture" (E) 
followed by severe hemorrhagic atheroma with minimal, linear lumen (arrow) without occlusion(F). Occlusive thrombosis con-
nected with hemorrhagic atheromasia at the site of a critical stenosis (G). Semilunar stenosis (H) with a normal half wall and 
minor lumen reduction. The concept of vessel wall remodeling to compensate plaque growth has not any support (very low 
frequency of this type of lesion versus severe concentric lumen reduction in the natural history of coronary heart disease).Cardiovascular Ultrasound 2004, 2:29 http://www.cardiovascularultrasound.com/content/2/1/29
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the radiofrequency signal allows a more detailed analysis
of various vessel components than does image analysis of
digitized videotape images and can be potentially
employed in real-time. This approach is expected to
improve tissue characterization [25].
Comment
The working hypothesis is to stabilize the atherosclerotic
plaque by increasing the thickness of the fibrous cap or by
regression of atheroma burden (1). However, present
imaging techniques (coronary cineangiography, angios-
copy, contrast magnetic resonance, contrast echocardiog-
raphy, nuclear scintigraphy, etc.) cannot provide adequate
clinical evaluation of plaque vulnerability. In particular,
ICUS is unable to provide discrimination between physi-
ological and pathological intimal thickening and to
define the shape of plaque, i.e. concentric or semilunar. In
fact, amongst 2121 coronary sections at the site of maxi-
mal lumen-diameter reduction the stenosis was concen-
tric in 70% of the cases (99% in supplying vessels of an
acute myocardial infarct). Furthermore, in 408 CHD
patients the maximal stenosis in each single case was less
than 69% in 68, 70%, in 67, 80% in 109 and >90% in
164. These data mean that the residual lumen ranged
from 900 to less than 50 µm and catheter of 1500 µm in
most instances must break the plaque, being the residual
lumen too small. Therefore, shape and contour of a
plaque can be altered with a misleading higher frequency
of semilunar stenosis giving an erroneous support to the
questionable concept of vessel wall remodelling follow-
ing an atherosclerotic plaque formation.
According to the previous data the main conclusions are:
1. The natural history of coronary atherosclerotic plaque
in the general population, inclusive of CHD patients, is
different from plaques obtained by experimental hyperc-
holesterol diet or found in familial hypercholesterolemia.
Most data refer to the latter as a valid model for the
human plaque. In particular, fatty streaks is not the start-
ing change of the myohyperplastic atherosclerotic plaque;
2. Emphasis is given to a "macrophagic inflammation" as
source of proteolytic and/or thrombogenic moleculae
causing plaque rupture. However, macrophagic reaction
belongs to a repair process to digest necrotic or extraneous
material rather than typical elements of an inflammatory
process, as lymphocytes, neutrophils. The assumption
that on increased number of labelled macrophages may
indicate a risk of rupture is questionable in human coro-
nary myohyperplastic plaque.
In the present review we have discussed the behaviour and
meaning of components of the human coronary athero-
sclerotic plaque to emphasize the inconsistency of the cur-
rent myths:
1. Experimental hypercholesterol model and correspond-
ent human conditions do not represent the natural history
of atherosclerosis in coronary arteries in the general
population.
2. Physiological intimal thickening can not be interpreted
as starting point of the atherosclerotic process.
3. Fatty streak does not represent the early atherosclerotic
lesion.
4. Calcification is not synonymous of severe stenosis.
5. Hemorrhage is not consequent to endothelial
fissuration.
6. Prevention of macrophage "inflammation" as source of
substances able to disrupt the fibrous cap allowing rup-
ture and thrombosis as well as identification of the thick-
ness of fibrous cap to diagnose a vulnerable plaque may
have little, if any, sense. Rupture and thrombosis may be
secondary phenomena and not the cause of an acute cor-
onary syndrome.
7. Degree and number of severe coronary plaques do not
predict onset, course, complications and death in CHD.
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Table 2: Echocardiographic approach to coronary arteries.
Technique % success Image quality Anatomic information (plaque) Functional information (flow)
Transtoracic 20 ± ± ±
Transesophageal 80 + + ++
Epicardic 90 ++ ++ -
Intracoronary 95 +++ +++ -
- = poor; + = sufficient; ++ = good; +++ = very goodCardiovascular Ultrasound 2004, 2:29 http://www.cardiovascularultrasound.com/content/2/1/29
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Dr. Riccardo Bigi and Dr. Lauro Cortigiani summarized
the use of ultrasound techniques in atherosclerotic plaque
imaging
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Table 1: Natural History of Human Coronary Atherosclerotic Plaque
Beliefs Facts
Transendothelial lipoprotein/cholesterol infiltration Nodular smooth myocell-elastic hyperplasia protruding in lumen
Fatty streaks Fibrous substitution
Macrophagic "inflammation" Proteoglycan accumulation below fibrous cap between media/intima
Necrotic core-atheroma under fibrous cap Interstitial/macrofagic (foam cells) storage of lipoprotein-cholesterol 
and/or calcium salts in proteoglycan pool
Rupture fibrous cap Plaque tridimensional growth by recurrence of previous phenomena
Thrombosis-Embolization Late vascularization of atherosclerotic intima
Divergency between dogma and heretic view is easily explained by the fact that the former is founded on experimental hypercholesterolemic 
plaque which more or less may correspond to plaques in the relatively small group of familial hypercholesterolemia in humans. Furthermore, the 
main arterial vessel examined was the aorta and in human pathology advanced plaque was not studied comparing study in different CHD patterns 
and pathologic and normal controls.
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